Charting Morphotoxicity With Complementary Embryo Models
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Dorian G Luijkx und 9 weiteren Autor:innen. Beteiligte Einrichtung: MERLN Institute for Technology-Inspired Regenerative Medicine, Department for Cell Biology-inspired Tissue Engineering, Maastricht University, Maastr…. Hauptthemen laut MEDLINE: Embryonic Development, Embryo, Mammalian, Toxicity Tests, Models, Biological. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maastrichts Universitair Medisch Centrum+ (MUMC+), Dutch Province of Limburg.
Abstract (Originalsprache)
Understanding developmental toxicity demands capturing the full spectrum of morphological diversity, or morphospace, that defines early human embryogenesis. Traditional toxicity testing methods, relying on animal models or simplified 2D cell cultures, inherently overlook the nuanced interplay between distinct developmental stages and cell lineages. Addressing this gap, we present an innovative high‐throughput screening approach leveraging three complementary 3D stem cell‐based embryo models: preimplantation stage blastoids, and early postimplantation stage epiblast‐like (EPICs) and amnion‐like clusters (AMNICs). Cultured in thermoformed microwell arrays, these models were systematically exposed to a library of 27 widely used compounds. Automated image‐based analyses allowed for precise quantification of morphotoxic effects. Key findings include the identification of compounds such as ascorbic acid and valproic acid (VPA), which demonstrated distinct and opposing effects across the different embryo models, highlighting developmental stage‐specific sensitivities. This integrative platform underscores the essential role of complementary embryo models to achieve robust and human‐relevant developmental toxicity assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MERLN Institute for Technology-Inspired Regenerative Medicine, Department for Cell Biology-inspired Tissue Engineering, Maastricht University, Maastricht, The Netherlands.
- GROW Research Institute for Oncology and Reproduction, Department of Obstetrics & Gynecology, Maastricht University, Maastricht, The Netherlands.
- MERLN Institute for Technology-Inspired Regenerative Medicine, Department for Complex Tissue Regeneration, Maastricht University, Maastricht, The Netherlands.
- MERLN Institute for Technology-Inspired Regenerative Medicine, Department for Instructive Biomaterials Engineering, Maastricht University, Maastricht, The Netherlands.
ORCID-Profile: Dorian G Luijkx, Pauline L Balder, Vinidhra Shankar, Pinak Samal, Timo Rademakers, Clemens A van Blitterswijk, Stefan Giselbrecht, Erik J Vrij
Förderung
- Maastrichts Universitair Medisch Centrum+ (MUMC+)
- Dutch Province of Limburg
Zitieren
APA
Luijkx, D. G., Balder, P. L., Verhagen, R. M. L., Shankar, V., Jutten, B., Samal, P., Rademakers, T., van Blitterswijk, C. A., Giselbrecht, S., & Vrij, E. J. (2026). Charting Morphotoxicity With Complementary Embryo Models. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503634
Vancouver
Luijkx DG, Balder PL, Verhagen RML, Shankar V, Jutten B, Samal P, et al. Charting Morphotoxicity With Complementary Embryo Models. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503634
BibTeX
@article{Luijkx2026,
author = {Luijkx, Dorian G and Balder, Pauline L and Verhagen, Romy M L and Shankar, Vinidhra and Jutten, Barry and Samal, Pinak and Rademakers, Timo and van Blitterswijk, Clemens A and Giselbrecht, Stefan and Vrij, Erik J},
title = {Charting Morphotoxicity With Complementary Embryo Models},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503634}
}
EUVIMED